Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

Journal:

Cancer Research

Published:

2025-09-15

DOI:

10.1158/0008-5472.can-25-0654

Affiliations:

11

Authors:

27

Go to article

Institutions	Authors	Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)	15.000000 15.000000	0.56
The Wistar Institute, United States of America (USA)	8.000000	0.30
The University of Chicago (UChicago), United States of America (USA)	2.000000	0.07
The University of Texas at Austin (UT Austin), United States of America (USA)	1.000000	0.04
University of Pennsylvania Health System (UPHS), United States of America (USA)	1.000000	0.04

Interested in Medical Biochemistry and Metabolomics?